Shattuck Labs Inc
3.84 - 4.08
2.59 - 22.62
Join Discuss about STTK with like-minded investors
Next Dividend Date
Shattuck Labs, Inc. operates as a clinical-stage biotechnology company . The Company focuses on developing a novel class of biologic medicines for the treatment of cancer and autoimmune diseases. Shattuck Labs serves customers in the State of Texas.